Primary myopathies and the heart

References

• Finsterer J, Stollberger C. Cardiac involvement in primary myopathies. Cardiology. 2000; 94: 1–11
   PubMed Web of Science ®Google Scholar
• Funakoshi M, Tsuchiya Y, Arahata K. Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy. Neuromusc Disord. 1999; 9: 108–14
   PubMed Web of Science ®Google Scholar
• Finsterer J, Stollberger C, Blazek G. Neuromuscular implications in left ventricular hypertrabeculation/noncompaction. Int J Cardiol. 2006; 110: 288–300
   PubMed Web of Science ®Google Scholar
• Srinivasan R, Hornyak JE, Badenhop DT, Koch LG. Cardiac rehabilitation after heart transplantation in a patient with Becker's muscular dystrophy: A case report. Arch Phys Med Rehabil. 2005; 86: 2059–61
   PubMed Web of Science ®Google Scholar
• Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2: Molecular, diagnostic and clinical spectrum. Neurology. 2003; 60: 657–64
   PubMed Web of Science ®Google Scholar
• Trevisan CP, Pastorello E, Armani M, Angelini C, Nante G, Tomelleri G, et al. Facioscapulohumeral muscular dystrophy and occurrence of heart arrhythmia. Eur Neurol. 2006; 56: 1–5
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Tzelepis GE, Athanasopoulos G, Maounis T, Douskou M, Papavasiliou A, et al. Cardiac and sternocleidomastoid muscle involvement in Duchenne muscular dystrophy: An MRI study. Chest. 2005; 127: 143–8
   PubMed Web of Science ®Google Scholar
• Cox GF, Kunkel LM. Dystrophies and heart disease. Curr Opin Cardiol. 1997; 12: 329–43
   PubMed Web of Science ®Google Scholar
• Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Hrenneaux M, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction system disease. N Engl J Med. 1999; 341: 1715–24
   PubMed Web of Science ®Google Scholar
• Ben Yaou R, Gueneau L, Demay L, Sotra S, Chikhaoui K, Richard P, et al. Heart involvement in lamin A/C related diseases. Arch Mal Coeur Vaiss. 2006; 99: 848–55
   PubMedGoogle Scholar
• Sanna T, Dello Russo A, Toniolo D, Vytopil M, Pelargonio G, De Martino G, et al. Cardiac features of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutations. Eur Heart J. 2003; 24: 2227–36
   PubMed Web of Science ®Google Scholar
• Mercuri E, Brown SC, Nihoyannopoulos P, Poulton J, Kinali M, Richard P, et al. Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle Nerve. 2005; 31: 602–9
   PubMed Web of Science ®Google Scholar
• deVisser M, deVoogt WG, laRiviere GV. The heart in Becker muscular dystrophy, facioscapulohumeral dystrophy, and Bethlem myopathy. Muscle Nerve. 1992; 15: 591–6
   PubMed Web of Science ®Google Scholar
• Galetta F, Franzoni F, Sposito R, Plantinga Y, Femia FR, Galluzzi F, et al. Subclinical cardiac involvement in patients with facioscapulohumeral muscular dystrophy. Neuromuscul Disord. 2005; 15: 403–8
   PubMed Web of Science ®Google Scholar
• Finsterer J, Stollberger C, Meng G. Cardiac involvement in facioscapulohumeral muscular dystrophy. Cardiology. 2005; 103: 81–3
   PubMed Web of Science ®Google Scholar
• Melacini P, Fanin M, Duggan DJ, Freda MP, Berardinelli A, Danieli GA, et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve. 1999; 22: 473–9
   PubMed Web of Science ®Google Scholar
• Cagliani R, Bresolin N, Prelle A, Gallanti A, Fortunato F, Sironi M, et al. A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Neurology. 2003; 61: 1513–9
   PubMed Web of Science ®Google Scholar
• Boito CA, Melacini P, Vianello A, Prandini P, Gavassini BF, Bagattin A, et al. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I. Arch Neurol. 2005; 62: 1894–9
   PubMed Web of Science ®Google Scholar
• Poppe M, Bourke J, Eagle M, Frosk P, Wrogemann K, Greenberg C, et al. Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol. 2004; 56: 738–41
   PubMed Web of Science ®Google Scholar
• Barresi R, DiBlasi C, Negri T, Brugnoni R, Vitali A, Felisari G, et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet. 2000; 37: 102–7
   PubMed Web of Science ®Google Scholar
• Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, et al. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscle dystrophy. Cell. 1999; 98: 465–74
   PubMed Web of Science ®Google Scholar
• Kuru S, Yasuma F, Wakayama T, Kimura S, Konagaya M, Aoki M, et al. A patient with limb girdle muscular dystrophy type 2B (LGMD2B) manifesting cardiomyopathy. Rinsho Shinkeigaku. 2004; 44: 375–8
   PubMedGoogle Scholar
• Calvo F, Teijeira S, Fernandez JM, Teijeiro A, Fernandez-Hojas R, Fernandez-Lopez XA, et al. Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients. Neuromuscul Disord. 2000; 10: 560–6
   PubMed Web of Science ®Google Scholar
• Gaul C, Deschauer M, Tempelmann C, Vielhaber S, Klein HU, Heinze HJ, et al. Cardiac involvement in limb-girdle muscular dystrophy 2I: Conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol. 2006; 253: 1317–22
   PubMed Web of Science ®Google Scholar
• Muller T, Krasnianski M, Witthaut R, Deschauer M, Zierz S. Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation. Neuromuscul Disord. 2005; 15: 372–6
   PubMed Web of Science ®Google Scholar
• Louhichi N, Triki C, Quijano-Roy S, Richard P, Makri S, Meziou M, et al. New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families. Neurogenetics. 2004; 5: 27–34
   PubMed Web of Science ®Google Scholar
• Toda T, Kobayashi K, Kondo-Iida E, Sasaki J, Nakamura Y. The Fukuyama congenital muscular dystrophy story. Neuromusc Disord. 2000; 10: 153–9
   PubMed Web of Science ®Google Scholar
• Murakami T, Hayashi YK, Noguchi S, Ogawa M, Nonaka I, Tanabe Y, et al. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol. 2006; 60: 597–602
   PubMed Web of Science ®Google Scholar
• Spyrou N, Philpot J, Foale R, Camici PG, Muntoni F. Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy. Am Heart J. 1998; 136: 474–6
   PubMed Web of Science ®Google Scholar
• Pethig K, Manz F, Kuhn H. Hypertrophic non-obstructive cardiomyopathy in rigid spine syndrome. Z Kardiol. 1995; 84: 490–5
   PubMedGoogle Scholar
• Thornton C. The myotonic dystrophies. Sem Neurol. 1999; 19: 25–33
   PubMed Web of Science ®Google Scholar
• Mahadevan MS, Yadava RS, Yu Q, Balijepalli S, Frenzel-McCardell CD, Bourne TD, et al. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat Genet. 2006; 38: 1066–70
   PubMed Web of Science ®Google Scholar
• Nakada T, Yonesaka S. Hypertrophic cardiomyopathy’ in a girl with adult-type myotonic dystrophy. Pediatr Int. 1999; 41: 586–8
   PubMed Web of Science ®Google Scholar
• Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res. 1997; 33: 13–22
   PubMed Web of Science ®Google Scholar
• Dello Russo A, Pelargonio G, Parisi Q, Santamaria M, Messano L, Sanna T, et al. Widespread electroanatomic alterations of right cardiac chambers in patients with myotonic dystrophy type 1. J Cardiovasc Electrophysiol. 2006; 17: 34–40
   PubMed Web of Science ®Google Scholar
• Merlevede K, Vermander D, Theys P, Legius E, Ector H, Robberecht W. Cardiac involvement and CTG expansion in myotonic dystrophy. J Neurol. 2002; 249: 693–8
   PubMed Web of Science ®Google Scholar
• Finsterer J, Stollberger C, Wegmann R, et al. Left ventricular hypertrabeculation in myotonic dystrophy type 1. Herz. 2001; 26: 287–90
   PubMed Web of Science ®Google Scholar
• Vinereanu D, Bajaj BP, Fenton-May J, Rogers MT, Madler CF, Fraser AG. Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities. Neuromuscul Disord. 2004; 14: 188–94
   PubMed Web of Science ®Google Scholar
• Di Leo R, Rodolico C, De Gregorio C, Recupero A, Coglitore S, Annesi G, et al. Cardiovascular autonomic control in myotonic dystrophy type 1: A correlative study with clinical and genetic data. Neuromuscul Disord. 2004; 14: 136–41
   PubMed Web of Science ®Google Scholar
• Finsterer J, Gharehbaghi-Schnell E, Stollberger C, et al. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet. 2001; 59: 350–5
   PubMed Web of Science ®Google Scholar
• Groh WJ, Lowe MR, Simmons Z, Bhakta D, Pascuzzi RM. Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1. Muscle Nerve 2005; 31: 719–24
   PubMed Web of Science ®Google Scholar
• Day JW, Roelofs R, Leroy B, Pech I, Benzow K, Ranum LPW. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromusc Disord. 1999; 9: 19–27
   PubMed Web of Science ®Google Scholar
• Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2: Molecular, diagnostic and clinical spectrum. Neurology. 2003; 60: 657–64
   PubMed Web of Science ®Google Scholar
• Goebel HH. Congenital myopathies in the new millennium. J Child Neurol. 2005; 20: 94–101
   PubMed Web of Science ®Google Scholar
• Michele DE, Albaya FP, Metzger JM. A nemaline myopathy mutation in alpha-tropomyosin causes defective regulation of striated muscle force production. J Clin Invest. 1999; 104: 1575–81
   PubMed Web of Science ®Google Scholar
• Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, et al. Mutations in the skeletal muscle (-actin gene in patients with actin myopathy and nemaline myopathy. Nature Genetics. 1999; 23: 208–13
   PubMed Web of Science ®Google Scholar
• D'Amico A, Graziano C, Pacileo G, Petrini S, Nowak KJ, Boldrini R, et al. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation. Neuromuscul Disord. 2006; 16: 548–52
   PubMed Web of Science ®Google Scholar
• Muller-Hocker J, Schafer S, Mendel B, Lochmuller H, Pongratz D. Nemaline cardiomyopathy in a young adult: An ultraimmunohistochemical study and review of the literature. Ultrastruct Pathol. 2000; 24: 407–16
   PubMed Web of Science ®Google Scholar
• Michele DE, Coutu P, Metzger JM. Divergent abnormal muscle relaxation by hypertrophic cardiomyopathy and nemaline myopathy mutant tropomyosins. Physiol Genomics. 2002; 9: 103–11
   PubMed Web of Science ®Google Scholar
• Fujita K, Nakano S, Yamamoto H, Ito H, Goto Y, Kusaka H. An adult case of congenital fiber type disproportion (CFTD) with cardiomyopathy. Rinsho Shinkeigaku. 2005; 45: 380–2
   PubMedGoogle Scholar
• Benkusky NA, Farrell EF, Valdivia HH. Ryanodine receptor channelopathies. Biochem Biophys Res Commun. 2004; 322: 1280–5
   PubMed Web of Science ®Google Scholar
• Al-Ruwaishid A, Vajsar J, Tein I, Benson L, Jay V. Centronuclear myopathy and cardiomyopathy requiring heart transplant. Brain Dev. 2003; 25: 62–6
   PubMed Web of Science ®Google Scholar
• Carlsson L, Thornell LE. Desmin-related myopathies in mice and man. Acta Physiol Scand. 2001; 171: 341–8
   PubMedGoogle Scholar
• Arbustini E, Morbini P, Grasso M, Fasani R, Verga L, Bellini O, et al. Restrictive cardiomyopathy, atrioventricular block and to subclinical myopathy in patients with desmin-immunoreactive material deposits. J Am Coll Cardiol. 1998; 31: 645–53
   PubMed Web of Science ®Google Scholar
• Selcen D, Engel AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol. 2005; 57: 269–76
   PubMed Web of Science ®Google Scholar
• Vatta M, Mohapatra B, Jimenez S, Sanchez X, Faulkner G, Perles Z, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol. 2003; 42: 2014–27
   PubMed Web of Science ®Google Scholar
• El-Menyar AA, Al-Suwaidi J, Gehani AA, Bener A. Clinical and histologic studies of a Qatari family with myofibrillar myopathy. Saudi Med J. 2004; 25: 1723–6
   PubMed Web of Science ®Google Scholar
• Nishino I, Malicdan MC, Murayama K, Nonaka I, Hayashi YK, Noguchi S. Molecular pathomechanism of distal myopathy with rimmed vacuoles. Acta Myol. 2005; 24: 80–3
   PubMedGoogle Scholar
• Kaplan J-C, Fontain B. Neuromuscular disorders: Gene location. Neuromusc Disord. 2006; 16: 64–90
   PubMedGoogle Scholar
• Stöllberger C, Finsterer J, Bittner RE. Angina for 14 years. Lancet. 1997; 349: 1292
   PubMed Web of Science ®Google Scholar
• Regalado JJ, Rodriguez MM, Ferrer PL. Infantile hypertrophic cardiomyopathy of glycogenosis type IX: Isolated cardiac phosphorylase kinase deficiency. Pediatr Cardiol. 1999; 20: 304–7
   PubMed Web of Science ®Google Scholar
• Metzl JD, Elias ER, Berul CI. An interesting case of infant sudden death: Severe hypertrophic cardiomyopathy in Pompe's disease. Pacing Clin Electrophysiol. 1999; 22: 821–2
   PubMed Web of Science ®Google Scholar
• Ewert R, Gulijew A, Wensel R, Dandel M, Hummel M, Vogel M, et al. Glycogenosis type IV as a seldom cause of cardiomyopathy – report about a successful heart transplantation. Z Kardiol. 1999; 88: 850–6
   PubMedGoogle Scholar
• Fanin M, Nascimbeni AC, Fulizio L, Spinazzi M, Melacini P, Angelini C, et al. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Am J Pathol. 2006; 168: 1309–20
   PubMed Web of Science ®Google Scholar
• Balmer C, Ballhausen D, Bosshard NU, Steinmann B, Boltshauser E, Bauersfeld U, et al. Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene. Eur J Pediatr. 2005; 164: 509–14
   PubMed Web of Science ®Google Scholar
• Morisawa Y, Fujieda M, Murakami N, Naruse K, Okada T, Morita H, et al. Lysosomal glycogen storage disease with normal acid maltase with early fatal outcome. J Neurol Sci. 1998; 160: 175–9
   PubMed Web of Science ®Google Scholar
• Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 2006; 27: 495–502
   PubMedGoogle Scholar
• Stanley CA. Carnitine deficiency disorders in children. Ann N Y Acad Sci. 2004; 1033: 42–51
   PubMed Web of Science ®Google Scholar
• Bonnet, D, Martin, D, Pascale, De Lonlay, Villain, E, Jouvet, P, Rabier, D, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation. 1999;100:2248–53.
   PubMed Web of Science ®Google Scholar
• Lamhonwah AM, Tein I. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun. 2006; 345: 1315–25
   PubMed Web of Science ®Google Scholar
• Asai T, Okumura K, Takahashi R, Matsui H, Numaguchi Y, Murakami H, et al. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res. 2006; 70: 566–77
   PubMed Web of Science ®Google Scholar
• Hou JW. Primary systemic carnitine deficiency presenting as recurrent Reye-like syndrome and dilated cardiomyopathy. Chang Gung Med J. 2002; 25: 832–7
   PubMedGoogle Scholar
• Orngreen MC, Duno M, Ejstrup R, Christensen E, Schwartz M, Sacchetti M, et al. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Ann Neurol. 2005; 57: 60–6
   PubMed Web of Science ®Google Scholar
• Oey NA, den Boer ME, Wijburg FA, Vekemans M, Auge J, Steiner C, et al. Long-chain fatty acid oxidation during early human development. Pediatr Res. 2005; 57: 755–9
   PubMed Web of Science ®Google Scholar
• Mathur A, Sims HF, Gopalakrishnan D, Gibson B, Rinaldo P, Vockley J, et al. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. Circulation. 1999; 99: 1337–43
   PubMed Web of Science ®Google Scholar
• Leonard JV, Shapira AHV. Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects. Lancet. 2000; 355: 299–304
   PubMed Web of Science ®Google Scholar
• Bonnet D, Rustin P, Rotig A, Le Bidois J, Munnich A, Vouhe P, et al. Heart transplantation in children with mitochondrial cardiomyopathy. Heart. 2001; 86: 570–3
   PubMed Web of Science ®Google Scholar
• Finsterer J, Stöllberger C. Hypertrabeculated left ventricle in mitochondriopathy. Heart. 1998; 80: 632
   PubMed Web of Science ®Google Scholar
• Houstek J, Klement P, Floryk D, Antonicka H, Hermanska J, Kalous M, et al. A novel deficiency of mitochondrial ATPase of nuclear origin. Hum Mol Genet. 1999; 8: 1967–74
   PubMed Web of Science ®Google Scholar
• Wallace DC. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J. 2000; 139: 70–85
   PubMed Web of Science ®Google Scholar
• Stöllberger, C, Finsterer, J. Disappearance of left ventricular hypertrabeculation/noncompaction after biventricular pacing in a patient with neuromuscular disorder. J Card Fail. 2007; (in press).
   Google Scholar
• Ozawa E, Noguchi S, Mizuno Y, Hagiwara Y, Yoshida M. From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy. Muscle Nerve. 1998; 21: 421–38
   PubMed Web of Science ®Google Scholar
• Skyllouriotis ML, Marx M, Bittner RE, Skyllouriotis P, Gross M, Wimmer M. Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome. Pediatr Neurol. 1997; 17: 61–6
   PubMed Web of Science ®Google Scholar
• Sharer JD. The adenine nucleotide translocase type 1 (ANT1): A new factor in mitochondrial disease. IUBMB Life. 2005; 57: 607–14
   PubMed Web of Science ®Google Scholar
• Atiq M, Iqbal S, Ibrahim S. Sengers disease: A rare association of hypertrophic cardiomyopathy and congenital cataracts. Indian J Pediatr. 2004; 71: 437–40
   PubMedGoogle Scholar
• Bleyl SB, Mumford BR, Brown-Harrison MC, Pagotto LT, Carey JC, Pysher TJ, et al. Xq28-linked noncompaction of the left ventricular myocardium: Prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet. 1997; 72: 257–65
   PubMed Web of Science ®Google Scholar
• Brady AN, Shehata BM, Fernhoff PM. X-linked fetal cardiomyopathy caused by a novel mutation in the TAZ gene. Prenat Diagn. 2006; 26: 462–5
   PubMed Web of Science ®Google Scholar
• Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol. 2007; 292: C33–C44
   PubMed Web of Science ®Google Scholar
• Spencer CT, Bryant RM, Day J, Gonzalez IL, Colan SD, Thompson WR, et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics. ee346 2006; 118: 337
   Google Scholar
• Merlini L, Villanova M, Sabatelli P, Malandrini A, Maraldi NM. Decreaed expression of laminin beta 1 in chromosome 21-linked Bethlem myopathy. Neuromusc Disord. 1999; 9: 326–9
   PubMed Web of Science ®Google Scholar
• Sewry CA, Muntoni F. Inherited disorders of the extracellular matrix. Curr Opin Neurol. 1999; 12: 519–26
   PubMed Web of Science ®Google Scholar
• van der Kooi AJ, de Voogt WG, Bertini E, Merlini L, Talim FB, Ben Yaou R, et al. Cardiac and pulmonary investigations in Bethlem myopathy. Arch Neurol. 2006; 63: 1617–21
   PubMed Web of Science ®Google Scholar
• Jung HH, Brandner S. Malignant McLeod myopathy. Muscle Nerve. 2002; 26: 424–7
   PubMed Web of Science ®Google Scholar
• Danek A, Rubio JP, Rampoldi L, Ho M, Dobson-Stone C, Tison F, et al. McLeod neuroacanthocytosis: Genotype and phenotype. Ann Neurol. 2001; 50: 755–64
   PubMed Web of Science ®Google Scholar
• Witt TN, Danek A, Reiter M, Heim MU, Dirschinger J, Olsen EG, et al. McLeod syndrome: A distinct form of neuroacanthocytosis. Report of two cases and literature review with emphasis on neuromuscular manifestations. J Neurol. 1992; 239: 302–6
   PubMed Web of Science ®Google Scholar
• Koul RL, Chand RP, Chacko A, Ali M, Brown KM, Bushnarmuth SR, et al. Severe autosomal recessive rippling muscle disease. Muscle Nerve. 2001; 24: 1542–7
   PubMed Web of Science ®Google Scholar
• Finsterer J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol Scand. 2006; 114: 217–38
   PubMed Web of Science ®Google Scholar
• Cripe LH, Barber BJ, Spicer RL, Wong BL, Weidner N, Benson DW, et al. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy. Neuromuscul Disord. 2006; 16: 745–8
   PubMed Web of Science ®Google Scholar
• Biggar WD, Harris VA, Eliasoph L, Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord. 2006; 16: 249–55
   PubMed Web of Science ®Google Scholar
• Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD, Cripe LH, et al. Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol. 2005; 26: 768–71
   PubMed Web of Science ®Google Scholar
• Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation. 2005; 112: 2799–804
   PubMed Web of Science ®Google Scholar
• Onder G, Vedova CD, Pahor M. Effects of ACE inhibitors on skeletal muscle. Curr Pharm Des. 2006; 12: 2057–64
   PubMed Web of Science ®Google Scholar
• Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet. 2006; 142: 77–85
   Google Scholar
• Klinge L, Straub V, Neudorf U, Schaper J, Bosbach T, Gorlinger K, et al. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: Results of a phase II clinical trial. Neuromuscul Disord. 2005; 15: 24–31
   PubMed Web of Science ®Google Scholar
• Ansong AK, Li JS, Nozik-Grayck E, Ing R, Kravitz RM, Idriss SF, et al. Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med. 2006; 8: 297–301
   PubMed Web of Science ®Google Scholar
• Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol. 2006; 59: 922–8
   PubMed Web of Science ®Google Scholar
• Townsend D, Yasuda S, Metzger J. Cardiomyopathy of Duchenne muscular dystrophy: Pathogenesis and prospect of membrane sealants as a new therapeutic approach. Expert Rev Cardiovasc Ther. 2007; 5: 99–109
   PubMedGoogle Scholar
• Jalil MA, Horiuchi M, Wakamatsu M, Li MX, Begum L, Suzuki K, et al. Attenuation of cardiac hypertrophy in carnitine-deficient juvenile visceral steatosis (JVS) mice achieved by lowering dietary lipid. J Biochem (Tokyo) 2006; 139: 263–70
   PubMed Web of Science ®Google Scholar
• Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association and the Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death–executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006; 27: 2099–140
   PubMed Web of Science ®Google Scholar
• Park OY, Ahn Y, Park WS, Lim JH, Park HW, Kim JH, et al. Rapid progression from hypertrophic cardiomyopathy to heart failure in a patient with Becker's muscular dystrophy. Eur J Heart Fail. 2005; 7: 684–8
   PubMed Web of Science ®Google Scholar
• Muller JS, Piko H, Schoser BG, Schlotter-Weigel B, Reilich P, Gurster S, et al. Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy. Neuromuscul Disord. 2006; 16: 432–6
   PubMed Web of Science ®Google Scholar
• Ohkubo M, Ino T, Shimazaki S, Yabuto K, Okada R, Sato T. Multicore myopathy associated with multiple pterygium syndrome and hypertrophic cardiomyopathy. Pediatr Cardiol. 1996; 17: 53–6
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Ikeda S, Katai S, Matsuda M, Hashimoto T, Haruta S, et al. Cytoplasmic body myopathy with hypertrophic cardiomyopathy. Intern Med. 1995; 34: 166–70
   PubMed Web of Science ®Google Scholar
• Case LE, Kishnani PS. Physical therapy management of Pompe disease. Genet Med. 2006; 8: 318–27
   PubMed Web of Science ®Google Scholar
• Scaglia F, Towbin JA, Craigen WJ, Belmont JW, Smith EO, Neish SR, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics. 2004; 114: 925–31
   PubMed Web of Science ®Google Scholar
• Schroder JM, May R, Shin YS, Sigmund M, Nase-Huppmeier S. Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis). Acta Neuropathol (Berl) 1993; 85: 419–30
   PubMed Web of Science ®Google Scholar
• DeAdamo P, Fassone L, Gedeon A, Janssen EAM, Bione S, Bolhuis PA, et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet. 1997; 61: 862–7
   PubMed Web of Science ®Google Scholar
• Willemsen MA, van Oort AM, ter Laak HJ, Sengers RC, Gabreels FJ. Multicore myopathy with restrictive cardiomyopathy. Acta Paediatr. 1997; 86: 1271–4
   PubMed Web of Science ®Google Scholar
• Ishiwata S, Nishiyama S, Seki A, Kojima S. Restrictive cardiomyopathy with complete atrioventricular block and distal myopathy with rimmed vacuoles. Jpn Circ J. 1993; 57: 928–33
   PubMedGoogle Scholar
• Campos Y, Martin MA, Caballero C, Rubio JC, de la Cruz F, Tunon T, et al. Single large-scale mitochondrial DNA deletion in a patient with encephalopathy, cardiomyopathy, and prominent intestinal pseudo-obstruction. Neuromuscul Disord. 2000; 10: 56–8
   PubMed Web of Science ®Google Scholar
• Berger PB, Duffy J, Reeder GS, Karon BL, Edwards WD. Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome. Mayo Clin Proc. 1994; 69: 162–5
   PubMed Web of Science ®Google Scholar
• Finsterer J, Stollberger C, Gaismayer K, Janssen B. Acquired noncompaction in Duchenne muscular dystrophy. Int J Cardiol. 2006; 106: 420–1
   PubMed Web of Science ®Google Scholar
• Ichida F, Tsubata S, Bowles KR, Hanenda N, Uese K, Miyawaki T. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation. 2001; 103: 1256–63
   PubMed Web of Science ®Google Scholar
• Chebel S, Ben Hamda K, Boughammoura A, Frih Ayed M, Ben Farhat MH. Cardiac involvement in Steinert's myotonic dystrophy. Rev Neurol (Paris) 2005; 161: 932–9
   PubMed Web of Science ®Google Scholar